IRIS Accounts Production v24.1.9.2 08604448 Board of Directors Board of Directors 1.8.22 31.7.23 31.7.23 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh086044482022-07-31086044482023-07-31086044482022-08-012023-07-31086044482021-07-31086044482021-08-012022-07-31086044482022-07-3108604448ns14:PoundSterling2022-08-012023-07-3108604448ns10:Director12022-08-012023-07-3108604448ns10:Director22022-08-012023-07-3108604448ns10:PrivateLimitedCompanyLtd2022-08-012023-07-3108604448ns10:SmallEntities2022-08-012023-07-3108604448ns10:AuditExempt-NoAccountantsReport2022-08-012023-07-3108604448ns10:SmallCompaniesRegimeForDirectorsReport2022-08-012023-07-3108604448ns10:SmallCompaniesRegimeForAccounts2022-08-012023-07-3108604448ns10:FullAccounts2022-08-012023-07-3108604448ns5:CurrentFinancialInstruments2023-07-3108604448ns5:CurrentFinancialInstruments2022-07-3108604448ns5:Non-currentFinancialInstruments2023-07-3108604448ns5:Non-currentFinancialInstruments2022-07-3108604448ns5:ShareCapital2023-07-3108604448ns5:ShareCapital2022-07-3108604448ns5:RetainedEarningsAccumulatedLosses2023-07-3108604448ns5:RetainedEarningsAccumulatedLosses2022-07-3108604448ns10:RegisteredOffice2022-08-012023-07-3108604448ns5:FurnitureFittings2022-07-3108604448ns5:FurnitureFittings2022-08-012023-07-3108604448ns5:FurnitureFittings2023-07-3108604448ns5:FurnitureFittings2022-07-3108604448ns5:UnlistedNon-exchangeTradedns5:CostValuation2022-07-3108604448ns5:UnlistedNon-exchangeTradedns5:AdditionsToInvestments2023-07-3108604448ns5:UnlistedNon-exchangeTradedns5:CostValuation2023-07-3108604448ns5:UnlistedNon-exchangeTraded2023-07-3108604448ns5:UnlistedNon-exchangeTraded2022-07-3108604448ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-07-3108604448ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2022-07-3108604448ns5:RetainedEarningsAccumulatedLosses2022-07-3108604448ns5:RetainedEarningsAccumulatedLosses2022-08-012023-07-31
REGISTERED NUMBER: 08604448















Unaudited Financial Statements for the Year Ended 31 July 2023

for

Sash Healthcare Limited

Sash Healthcare Limited (Registered number: 08604448)






Contents of the Financial Statements
for the Year Ended 31 July 2023




Page

Balance Sheet 1

Notes to the Financial Statements 3


Sash Healthcare Limited (Registered number: 08604448)

Balance Sheet
31 July 2023

31.7.23 31.7.22
Notes £ £
Fixed assets
Tangible assets 4 362 483
Investments 5 106,402 100,402
106,764 100,885

Current assets
Cash at bank 7,848 64,943

Creditors
Amounts falling due within one year 6 (3,643 ) (21,492 )
Net current assets 4,205 43,451
Total assets less current liabilities 110,969 144,336

Creditors
Amounts falling due after more than
one year

7

(31,000

)

(41,000

)
Net assets 79,969 103,336

Capital and reserves
Called up share capital 100 100
Retained earnings 9 79,869 103,236
Shareholders' funds 79,969 103,336

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Sash Healthcare Limited (Registered number: 08604448)

Balance Sheet - continued
31 July 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 July 2024 and were signed on its behalf by:




Dr Atif Saeed - Director



Dr Hina Zahur - Director


Sash Healthcare Limited (Registered number: 08604448)

Notes to the Financial Statements
for the Year Ended 31 July 2023

1. Statutory information

Sash Healthcare Limited is a private company, limited by shares , registered in Not specified/Other. The company's registered number and registered office address are as below:

Registered number: 08604448

Registered office: Marshall House, Suite 21/25 124 Middleton
Morden
SM4 6RW

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. Employees and directors

The average number of employees during the year was 1 (2022 - NIL ) .

Sash Healthcare Limited (Registered number: 08604448)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2023

4. Tangible fixed assets
Fixtures
and
fittings
£
Cost
At 1 August 2022
and 31 July 2023 5,655
Depreciation
At 1 August 2022 5,172
Charge for year 121
At 31 July 2023 5,293
Net book value
At 31 July 2023 362
At 31 July 2022 483

5. Fixed asset investments
Unlisted
investments
£
Cost
At 1 August 2022 100,402
Additions 6,000
At 31 July 2023 106,402
Net book value
At 31 July 2023 106,402
At 31 July 2022 100,402

6. Creditors: amounts falling due within one year
31.7.23 31.7.22
£ £
Trade creditors 981 6,981
Corporation tax 2,662 14,511
3,643 21,492

7. Creditors: amounts falling due after more than one year
31.7.23 31.7.22
£ £
Bank loans (see note 8) 31,000 41,000

Sash Healthcare Limited (Registered number: 08604448)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2023

8. Loans

An analysis of the maturity of loans is given below:

31.7.23 31.7.22
£ £
Amounts falling due between one and two years:
Bank loans > 1 year 31,000 41,000

9. Reserves
Retained
earnings
£

At 1 August 2022 103,236
Profit for the year 11,225
Dividends (34,592 )
At 31 July 2023 79,869